Clinical Trials Logo

Stage IIIC Breast Cancer AJCC v7 clinical trials

View clinical trials related to Stage IIIC Breast Cancer AJCC v7.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT02037529 Suspended - Clinical trials for Invasive Breast Carcinoma

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Start date: January 17, 2014
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well eribulin mesylate or paclitaxel work as first- or second-line therapy in treating patients with stage IIIC-IV breast cancer that has come back. Drugs used in chemotherapy, such as eribulin mesylate and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.